Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
433.00    3.00 (0.70%)
Bid:
431.00
Ask:
433.50
Spread: 2.50 (0.58%)
Market Cap: £212.96m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Trading Update

7 Jan 2015 07:00

RNS Number : 4767B
Zotefoams PLC
07 January 2015
 



Zotefoams plc

("Zotefoams" or "the Company")

 

Trading Update

 

7 January 2015 - Zotefoams, a world leader in cellular material technology, today provides a trading update following the Company's financial year end on 31 December 2014.

 

For the year ended 31 December 2014 Zotefoams will report sales growth in all major areas of the business with overall sales approximately 10%1 ahead of 2013 in reporting currency which is equivalent to growth of approximately 15% in constant currency.

 

In constant currency, High-Performance Products sales grew by approximately 60% while sales in MuCell Extrusion, our technology licensing business, increased by approximately 40%. Polyolefin sales volumes increased by 9% in the year, although the fourth quarter was impacted by delayed shipments. While it is normal to have some carry-over of planned shipments from month to month, the level was approximately £1.5m higher than we expected. This shortfall, which will despatch in early 2015, will result in a lower level of profitability from Polyolefin foams than previously anticipated. These delays were a result of unanticipated administrative bottlenecks following the implementation of our new ERP IT system. While we are confident that all substantive issues have now been resolved there was insufficient time to ship all orders before year end. We enter 2015 with a revenue backlog from Polyolefin foams as well as a strong order book for the start of the new year.

 

The Board expects to report an earnings outcome slightly below the lower end of market expectations when preliminary results are announced on Tuesday 17 March, 2015. With 2014 seeing strong operating profit2 growth and sales momentum into 2015, the Board remains confident of continued progress in the future.

 

 

Enquiries:

Zotefoams plc

0208-664-1600

David Stirling, Managing Director

Clifford Hurst, Finance Director

FTI Consulting

0203-727-1000

Victoria Foster Mitchell, Simon Conway

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular material technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces lightweight foams in Croydon, UK and Kentucky, USA for diverse markets worldwide through its global sales force. Zotefoams also owns and licenses patented MuCell® microcellular foam technology from a base in Massachusetts, USA to customers worldwide and sells T-Tubes® advanced insulation systems made from its patented ZOTEK® fluoropolymer foams.

 

www.zotefoams.com

 

ZOTEK® is a registered trademark of Zotefoams plc. MuCell® is a registered trademark of Trexel Inc. T-Tubes® is a registered trademark of UFP Technologies Inc.

 

 

1 Sales made by joint ventures as well as those made by Zotefoams plc and its subsidiaries.

2 Before exceptional items

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKMGGMFVMGKZZ
Date   Source Headline
4th Jun 20193:44 pmRNSHolding(s) in Company
4th Jun 20193:06 pmRNSDirector/PDMR Shareholding
28th May 201911:54 amRNSHolding(s) in Company
28th May 20199:38 amRNSHolding(s) in Company
21st May 20195:36 pmRNSDirector/PDMR Shareholding
21st May 201912:20 pmRNSHolding(s) in Company
20th May 20197:00 amRNSHolding(s) in Company
16th May 201912:46 pmRNSDirector/PDMR Shareholding
15th May 20193:51 pmRNSResult of AGM
15th May 20197:00 amRNSTrading Update
7th May 20199:11 amRNSDirector Declaration
25th Apr 20194:40 pmRNSDirector/PDMR Shareholding
17th Apr 20192:35 pmRNS2018 Annual Report and Notice of the 2019 AGM
16th Apr 20194:41 pmRNSDirector/PDMR Shareholding
12th Apr 20193:54 pmRNSDirector/PDMR Shareholding
4th Apr 201911:01 amRNSHolding(s) in Company
29th Mar 201912:57 pmRNSHolding(s) in Company
22nd Mar 20192:21 pmRNSHolding(s) in Company
19th Mar 20197:00 amRNSFinal Results
18th Mar 20194:12 pmRNSHolding(s) in Company
14th Mar 201911:46 amRNSDirector/PDMR Shareholding
5th Mar 20195:55 pmRNSDirector Declaration
14th Feb 20195:02 pmRNSDirector/PDMR Shareholding
28th Jan 20195:09 pmRNSHolding(s) in Company
28th Jan 20197:00 amRNSNotice of Results
15th Jan 20195:08 pmRNSDirector/PDMR Shareholding
15th Jan 20192:06 pmRNSHolding(s) in Company
9th Jan 20193:48 pmRNSHolding(s) in Company
7th Jan 201911:41 amRNSHolding(s) in Company
7th Jan 201911:37 amRNSHolding(s) in Company
7th Jan 201910:37 amRNSHolding(s) in Company
7th Jan 201910:33 amRNSHolding(s) in Company
19th Dec 20189:11 amRNSHolding(s) in Company
13th Dec 20181:16 pmRNSDirector/PDMR Shareholding
10th Dec 20187:00 amRNSHolding(s) in Company
27th Nov 20185:26 pmRNSHolding(s) in Company
19th Nov 20185:37 pmRNSHolding(s) in Company
13th Nov 201812:36 pmRNSDirector/PDMR Shareholding
8th Nov 20187:30 amRNSHolding(s) in Company
7th Nov 201812:50 pmRNSHolding(s) in Company
1st Nov 20187:00 amRNSTrading Update
12th Oct 20185:06 pmRNSDirector/PDMR Shareholding
12th Sep 20184:14 pmRNSDirector/PDMR Shareholding
22nd Aug 20184:34 pmRNSHolding(s) in Company
22nd Aug 20182:05 pmRNSHolding(s) in Company
15th Aug 201811:59 amRNSHolding(s) in Company
15th Aug 201811:53 amRNSDirector/PDMR Shareholding
7th Aug 20187:00 amRNSInterim Results
25th Jul 20182:47 pmRNSHolding(s) in Company
25th Jul 20182:47 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.